Assessing the Causal Association Between COVID-19 and Graves Disease: Mendelian Randomization Study
Abstract BackgroundGraves disease (GD) is an autoimmune thyroid disorder characterized by hyperthyroidism and autoantibodies. The COVID-19 pandemic has raised questions about its potential relationship with autoimmune diseases like GD. ObjectiveThis study aims to i...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2025-04-01
|
| Series: | JMIR Formative Research |
| Online Access: | https://formative.jmir.org/2025/1/e66003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850199577894846464 |
|---|---|
| author | Hui Nian Yu Bai Hua Yu |
| author_facet | Hui Nian Yu Bai Hua Yu |
| author_sort | Hui Nian |
| collection | DOAJ |
| description |
Abstract
BackgroundGraves disease (GD) is an autoimmune thyroid disorder characterized by hyperthyroidism and autoantibodies. The COVID-19 pandemic has raised questions about its potential relationship with autoimmune diseases like GD.
ObjectiveThis study aims to investigate the causal association between COVID-19 and GD through Mendelian randomization (MR) analysis and assess the impact of COVID-19 on GD.
MethodsWe conducted an MR study using extensive genome-wide association study data for GD and COVID-19 susceptibility and its severity. We used stringent single nucleotide polymorphism selection criteria and various MR methodologies, including inverse-variance weighting, MR-Egger, and weighted median analyses, to assess causal relationships. We also conducted tests for directional pleiotropy and heterogeneity, as well as sensitivity analyses.
ResultsThe MR analysis, based on the largest available dataset to date, did not provide evidence supporting a causal relationship between COVID-19 susceptibility (odds ratio [OR] 0.989, 95% CI 0.405‐2.851; PPP
ConclusionsThis comprehensive MR study does not provide sufficient evidence to support a causal relationship between COVID-19 and the onset or exacerbation of GD. These results contribute to a better understanding of the potential association between COVID-19 and autoimmune diseases, alleviating concerns about a surge in autoimmune thyroid diseases due to the pandemic. Further research is warranted to explore this complex relationship thoroughly. |
| format | Article |
| id | doaj-art-b2634ee8d38c416ab9187e417b37ee3f |
| institution | OA Journals |
| issn | 2561-326X |
| language | English |
| publishDate | 2025-04-01 |
| publisher | JMIR Publications |
| record_format | Article |
| series | JMIR Formative Research |
| spelling | doaj-art-b2634ee8d38c416ab9187e417b37ee3f2025-08-20T02:12:34ZengJMIR PublicationsJMIR Formative Research2561-326X2025-04-019e66003e6600310.2196/66003Assessing the Causal Association Between COVID-19 and Graves Disease: Mendelian Randomization StudyHui Nianhttp://orcid.org/0009-0001-1152-7073Yu Baihttp://orcid.org/0009-0001-4273-8383Hua Yuhttp://orcid.org/0000-0002-1599-6192 Abstract BackgroundGraves disease (GD) is an autoimmune thyroid disorder characterized by hyperthyroidism and autoantibodies. The COVID-19 pandemic has raised questions about its potential relationship with autoimmune diseases like GD. ObjectiveThis study aims to investigate the causal association between COVID-19 and GD through Mendelian randomization (MR) analysis and assess the impact of COVID-19 on GD. MethodsWe conducted an MR study using extensive genome-wide association study data for GD and COVID-19 susceptibility and its severity. We used stringent single nucleotide polymorphism selection criteria and various MR methodologies, including inverse-variance weighting, MR-Egger, and weighted median analyses, to assess causal relationships. We also conducted tests for directional pleiotropy and heterogeneity, as well as sensitivity analyses. ResultsThe MR analysis, based on the largest available dataset to date, did not provide evidence supporting a causal relationship between COVID-19 susceptibility (odds ratio [OR] 0.989, 95% CI 0.405‐2.851; PPP ConclusionsThis comprehensive MR study does not provide sufficient evidence to support a causal relationship between COVID-19 and the onset or exacerbation of GD. These results contribute to a better understanding of the potential association between COVID-19 and autoimmune diseases, alleviating concerns about a surge in autoimmune thyroid diseases due to the pandemic. Further research is warranted to explore this complex relationship thoroughly.https://formative.jmir.org/2025/1/e66003 |
| spellingShingle | Hui Nian Yu Bai Hua Yu Assessing the Causal Association Between COVID-19 and Graves Disease: Mendelian Randomization Study JMIR Formative Research |
| title | Assessing the Causal Association Between COVID-19 and Graves Disease: Mendelian Randomization Study |
| title_full | Assessing the Causal Association Between COVID-19 and Graves Disease: Mendelian Randomization Study |
| title_fullStr | Assessing the Causal Association Between COVID-19 and Graves Disease: Mendelian Randomization Study |
| title_full_unstemmed | Assessing the Causal Association Between COVID-19 and Graves Disease: Mendelian Randomization Study |
| title_short | Assessing the Causal Association Between COVID-19 and Graves Disease: Mendelian Randomization Study |
| title_sort | assessing the causal association between covid 19 and graves disease mendelian randomization study |
| url | https://formative.jmir.org/2025/1/e66003 |
| work_keys_str_mv | AT huinian assessingthecausalassociationbetweencovid19andgravesdiseasemendelianrandomizationstudy AT yubai assessingthecausalassociationbetweencovid19andgravesdiseasemendelianrandomizationstudy AT huayu assessingthecausalassociationbetweencovid19andgravesdiseasemendelianrandomizationstudy |